CMV prophylaxis after renal transplantation with immunoglobulin or CMV‐hyperimmunoglobulin — a prospective clinical trial von Stippel, D., Wienand, P., Weißenberg, N., Baldamus, C., Kruppenbacher, U.

Volltext

Distinct prevalence of antibodies to the E2 protein of GB virus C/hepatitis G virus in different parts of the world von Ross, R. S., Viazov, S., Schmitt, U., Schmolke, S., Tacke, M., Ofenloch-Haehnle, B., Holtmann, M., Müller, N., Da Villa, G., Yoshida, C. F., Oliveira, J. M., Szabo, A., Paladi, N., Kruppenbacher, J. P., Philipp, Th, Roggendorf, M.

Volltext

Does the concurrent administration of an inactivated hepatitis A vaccine influence the immune response to other travelers vaccines? von BOCK, H. L, KRUPPENBACHER, J. P, BIENZLE, U, DE CLERCQ, N. A, HOFMANN, F, CLEMENS, R. L

Volltext

Immunogenicity of an inactivated hepatitis A vaccine administered according to two different schedules and the interference of other “travellers” vaccines with the immune response... von Bienzle, U., Bock, H.L., Kruppenbacher, J.P., Hofmann, F., Vogel, G.E., Clemens, R.

Volltext

Anti-HAV seroprevalence in German travellers and hepatitis A vaccination in immune subjects von Bienzle, U., Bock, H.L., Meister, W., Clemens, R., Kruppenbacher, J.P.

Volltext

Seroconversion against human herpesvirus-6 (and other herpesviruses) and clinical illness von Kirchesch, H, Mertens, T, Burkhardt, U, Kruppenbacher, J P, Höffken, A, Eggers, H J

Volltext

Seroconversion against human herpesvirus-6 (and other herpesviruses) and clinical illness von Kirchesch, H, Mertens, T, Burkhardt, U, Kruppenbacher, J P, Höffken, A, Eggers, H J

Volltext